Nifty
:
22713.10
Sensex
:
73319.55
33.70 (0.15%)
185.23 (0.25%)
Nifty
Sensex
:
:
22713.10
73319.55
33.70 (0.15%)
185.23 (0.25%)

Jubilant Ingrevia Ltd.

Chemicals

Rating :
54/99

BSE: 543271 | NSE: JUBLINGREA

NSE BSE
579.15
02-Apr-2026
  • Open
  • High
  • Low
  • Previous Close
  •  573
  •  582.5
  •  553.75
  •  573.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  137344
  •  78044055.95
  •  851.8
  •  535.2

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,223.97
  • 34.74
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,971.55
  • 0.86%
  • 2.99

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 45.22%
  • 2.29%
  • 18.28%
  • FII
  • DII
  • Others
  • 6.15%
  • 22.01%
  • 6.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 43.60
  • -4.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 34.69
  • -1.05

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 35.81
  • -6.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 36.72
  • 39.96

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 3.40
  • 3.35

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 23.02
  • 19.47

Earnings Forecasts:

(Updated: 04-04-2026)
Description
2024
2025
2026
2027
Adj EPS
15.89
17.27
23.08
29
P/E Ratio
36.45
33.54
25.09
19.97
Revenue
4177.62
4400.81
5019.95
5715.14
EBITDA
525.43
553.42
697.29
855.89
Net Income
251.18
272.88
353.76
448.12
ROA
5.15
8.36
10.45
11.56
P/B Ratio
3.15
2.95
2.70
2.43
ROE
8.87
8.98
10.76
12.3
FCFF
71.96
199.57
213.7
317.08
FCFF Yield
0.77
2.14
2.3
3.41
Net Debt
648.84
804.7
987.57
1076.66
BVPS
183.77
196.55
214.29
238.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
1,050.99
1,056.77
-0.55%
1,120.73
1,045.24
7.22%
1,037.95
1,024.34
1.33%
1,051.26
1,074.44
-2.16%
Expenses
924.44
918.48
0.65%
985.21
920.67
7.01%
895.81
914.81
-2.08%
904.57
983.20
-8.00%
EBITDA
126.55
138.29
-8.49%
135.52
124.57
8.79%
142.14
109.53
29.77%
146.69
91.24
60.77%
EBIDTM
12.04%
13.09%
12.09%
11.92%
13.69%
10.69%
13.95%
8.49%
Other Income
9.42
9.43
-0.11%
10.81
10.46
3.35%
11.22
9.57
17.24%
8.36
9.50
-12.00%
Interest
12.46
12.39
0.56%
12.16
15.07
-19.31%
12.69
14.27
-11.07%
13.91
13.62
2.13%
Depreciation
45.04
39.76
13.28%
41.23
39.60
4.12%
40.84
38.88
5.04%
39.39
35.72
10.27%
PBT
65.43
95.57
-31.54%
92.94
80.36
15.65%
99.83
65.95
51.37%
101.75
51.40
97.96%
Tax
18.51
26.20
-29.35%
23.39
21.22
10.23%
24.67
17.29
42.68%
27.73
22.10
25.48%
PAT
46.92
69.37
-32.36%
69.55
59.14
17.60%
75.16
48.66
54.46%
74.02
29.30
152.63%
PATM
4.46%
6.56%
6.21%
5.66%
7.24%
4.75%
7.04%
2.73%
EPS
2.97
4.39
-32.35%
4.40
3.73
17.96%
4.75
3.08
54.22%
4.68
1.85
152.97%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
4,260.93
4,177.62
4,135.80
4,772.69
4,949.36
684.13
0.00
Net Sales Growth
1.43%
1.01%
-13.34%
-3.57%
623.45%
0
 
Cost Of Goods Sold
2,208.95
2,107.27
2,142.59
2,581.57
2,839.89
369.95
0.00
Gross Profit
2,051.98
2,070.35
1,993.21
2,191.11
2,109.47
314.18
0.00
GP Margin
48.16%
49.56%
48.19%
45.91%
42.62%
45.92%
0
Total Expenditure
3,710.03
3,658.53
3,714.68
4,225.55
4,117.54
567.01
0.17
Power & Fuel Cost
-
463.54
521.15
709.11
468.23
51.71
0.00
% Of Sales
-
11.10%
12.60%
14.86%
9.46%
7.56%
0
Employee Cost
-
418.05
383.94
343.48
327.28
49.02
0.00
% Of Sales
-
10.01%
9.28%
7.20%
6.61%
7.17%
0
Manufacturing Exp.
-
273.77
275.14
288.14
236.16
56.37
0.00
% Of Sales
-
6.55%
6.65%
6.04%
4.77%
8.24%
0
General & Admin Exp.
-
125.42
146.40
89.68
81.60
12.08
0.17
% Of Sales
-
3.00%
3.54%
1.88%
1.65%
1.77%
0
Selling & Distn. Exp.
-
236.16
207.23
177.84
124.85
21.96
0.00
% Of Sales
-
5.65%
5.01%
3.73%
2.52%
3.21%
0
Miscellaneous Exp.
-
34.32
38.23
35.73
39.52
5.91
0.00
% Of Sales
-
0.82%
0.92%
0.75%
0.80%
0.86%
0
EBITDA
550.90
519.09
421.12
547.14
831.82
117.12
-0.17
EBITDA Margin
12.93%
12.43%
10.18%
11.46%
16.81%
17.12%
0
Other Income
39.81
37.82
35.30
33.37
31.49
2.60
0.00
Interest
51.22
55.64
52.66
21.58
30.94
7.33
0.00
Depreciation
166.50
157.63
136.17
122.18
123.39
22.06
0.00
PBT
359.95
343.64
267.60
436.75
708.99
90.33
-0.17
Tax
94.30
92.44
84.72
129.22
232.23
23.03
0.00
Tax Rate
26.20%
26.90%
31.66%
29.59%
32.76%
29.76%
0.00%
PAT
265.65
251.18
182.89
307.50
476.71
54.36
-0.17
PAT before Minority Interest
265.65
251.18
182.89
307.50
476.71
54.36
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.23%
6.01%
4.42%
6.44%
9.63%
7.95%
0
PAT Growth
28.66%
37.34%
-40.52%
-35.50%
776.95%
-
 
EPS
16.68
15.77
11.48
19.30
29.93
3.41
-0.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
2,927.08
2,737.47
2,666.23
2,433.12
1,922.94
-0.12
Share Capital
15.81
15.80
15.90
15.90
15.93
0.05
Total Reserves
2,894.03
2,712.14
2,646.32
2,415.78
1,907.01
-0.17
Non-Current Liabilities
687.05
695.62
403.19
296.32
548.86
0.00
Secured Loans
363.21
425.57
150.00
99.69
455.84
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
66.55
64.81
66.13
67.93
69.44
0.00
Current Liabilities
1,401.00
1,286.08
1,179.58
1,052.78
894.33
0.17
Trade Payables
814.92
766.67
801.12
797.77
694.06
0.17
Other Current Liabilities
232.17
195.23
110.17
101.60
183.03
0.00
Short Term Borrowings
303.95
283.00
246.73
129.06
0.00
0.00
Short Term Provisions
49.95
41.18
21.56
24.34
17.24
0.00
Total Liabilities
5,015.13
4,719.17
4,249.00
3,782.22
3,366.13
0.05
Net Block
2,580.97
2,538.71
1,846.18
1,798.28
1,805.10
0.00
Gross Block
3,617.30
3,443.76
2,625.80
2,462.87
2,352.65
0.00
Accumulated Depreciation
1,036.32
905.04
779.62
664.59
547.56
0.00
Non Current Assets
3,161.90
2,939.27
2,430.99
2,017.65
1,942.54
0.00
Capital Work in Progress
525.18
331.35
524.93
174.22
65.08
0.00
Non Current Investment
20.50
15.49
8.23
6.19
50.24
0.00
Long Term Loans & Adv.
23.91
37.47
42.67
25.86
21.63
0.00
Other Non Current Assets
11.33
16.25
8.97
13.11
0.50
0.00
Current Assets
1,853.22
1,779.90
1,818.00
1,764.57
1,423.59
0.05
Current Investments
16.21
0.00
0.00
0.00
0.00
0.00
Inventories
943.41
941.30
1,035.11
911.16
609.10
0.00
Sundry Debtors
607.13
571.97
510.89
580.91
471.03
0.00
Cash & Bank
98.73
79.60
84.59
48.53
116.60
0.05
Other Current Assets
187.74
47.53
39.26
83.05
226.85
0.00
Short Term Loans & Adv.
135.27
139.50
148.16
140.92
151.85
0.00
Net Current Assets
452.23
493.83
638.43
711.79
529.26
-0.12
Total Assets
5,015.12
4,719.17
4,248.99
3,782.22
3,366.13
0.05

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
508.10
429.98
462.46
452.74
112.28
0.00
PBT
343.62
267.61
436.71
708.94
77.39
-0.17
Adjustment
221.26
202.50
148.28
174.29
45.45
0.00
Changes in Working Capital
22.79
5.87
-45.15
-302.39
0.95
0.17
Cash after chg. in Working capital
587.67
475.98
539.84
580.84
123.79
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-79.57
-46.00
-77.38
-128.10
-11.51
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-392.82
-568.78
-471.89
-71.86
-43.66
0.00
Net Fixed Assets
-177.31
-340.05
-466.36
-217.18
-2,299.50
Net Investments
-12.80
-125.07
-32.70
-4.30
-134.89
Others
-202.71
-103.66
27.17
149.62
2,390.73
Cash from Financing Activity
-128.76
144.13
41.60
-417.75
-72.36
0.05
Net Cash Inflow / Outflow
-13.47
5.34
32.17
-36.87
-3.74
0.05
Opening Cash & Equivalents
78.78
72.72
37.61
73.34
0.05
0.00
Closing Cash & Equivalent
69.36
78.78
72.72
37.61
73.34
0.05

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
184.02
172.66
167.47
152.96
120.73
-2.32
ROA
5.16%
4.08%
7.66%
13.34%
3.23%
-332.00%
ROE
8.91%
6.79%
12.07%
21.89%
5.65%
0.00%
ROCE
11.16%
9.80%
16.01%
28.84%
6.86%
0.00%
Fixed Asset Turnover
1.19
1.37
1.88
2.06
0.29
0.00
Receivable days
51.39
47.67
41.69
38.75
250.55
0.00
Inventory Days
82.14
87.01
74.31
56.00
323.99
0.00
Payable days
136.97
133.54
113.03
95.87
342.47
0.00
Cash Conversion Cycle
-3.44
1.13
2.97
-1.12
232.07
0.00
Total Debt/Equity
0.26
0.27
0.15
0.09
0.28
0.00
Interest Cover
7.18
6.08
21.24
23.92
11.56
0.00

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021

News Update:


  • Jubilant Ingrevia acquires 100% equity stake in Remidex Pharma
    1st Apr 2026, 10:26 AM

    This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4)

    Read More
  • Jubilant Ingrevia’s arm begins commercial production of Agro Intermediate at Bharuch Site
    23rd Mar 2026, 14:11 PM

    The dispatch of material has started from March 21, 2026

    Read More
  • Jubilant Ingrevia inks pact to acquire 100% stake in Remidex Pharma
    14th Mar 2026, 12:38 PM

    Cost of acquisition is Rs 16.5 crore subject to customary closing conditions

    Read More
  • Jubilant Ingrevia - Quarterly Results
    5th Feb 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.